Keywords: unigene, license, calcitonin, product, w-l, warner-lambert, signed
Unigene To License Calcitonin Product To W-L?
Article | 03 July 1997
- Unigene and Warner-Lambert have signed a letter of intent for aworldwide licensing agreement for Unigene's oral calcitonin. W-L would develop ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
